Elecoglipron
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants
AstraZeneca · Phase 1 · Active, not recruiting · Enrollment 48
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Group 1: Period 1 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 1: Period 2 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 1: Period 3 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 1: Period 4 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 1: Period 5 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 1: Period 6 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 1 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 2 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 3 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 4 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 5 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 6 | Healthy Participants | n/r | n/r | n/r | n/r |
| Group 2: Period 7 | Healthy Participants | n/r | n/r | n/r | n/r |